The largest database of trusted experimental protocols

7 protocols using aperio image analysis software

1

Prognostic impact of HAF in metastatic CCRCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
TMAs were prepared from patients with metastatic CCRCC enrolled in phase II trials at the U.T.M.D. Anderson Cancer Center and were treated with sorafenib or sorafenib plus interferon (25 (link)). Three cores were obtained per patient and stained using HAF monoclonal antibody (20 (link)). Images were scanned using an Aperio AT2 slide scanner, and HAF nuclear staining was quantitated using Aperio Image analysis software (Leica Biosystems Inc, Buffalo Grove, IL). TCGA data was accessed using OncoLnc (26 ). Both datasets were stratified into two equal groups of high or low HAF transcript or protein. Kaplan Meier survival curves, p-values and hazard ratios were calculated using Prism 7.0.
+ Open protocol
+ Expand
2

Biomarker Stability in Glioblastoma Progression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test the stability of proposed pharmacodynamic biomarkers (pRB, pFOXM1, MIB1, and cleaved caspase-3), we analyzed a historical cohort of 10 matched primary and recurrent glioblastoma patients who received standard-of-care Stupp regimen and were not enrolled in the study. FFPE tissues were stained with anti-pRB (Cell Signaling, #8516, 1:400), anti-pFOXM1 (Cell Signaling, #14655, 1:200), anti-MIB1 (DAKO, M724029, 1:100), and anti-cleaved caspase-3 (Cell Signaling, #9661, 1:300) using our standardized immunohistochemistry protocol with the BOND RX automated system (Leica Biosystems, Wetzlar, Germany). The stained slides were imaged and analyzed by a board-certified pathologist, and Aperio Image analysis software (Leica Biosystems) was used to assess differences in positivity for pRB, MIB1, and cleaved caspase-3 in primary vs. recurrent tumors. There were no significant differences between primary and recurrent tissues in the levels of the tested biomarkers.
+ Open protocol
+ Expand
3

Histological Analysis of YAP and Ki67 in Kidney Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
For histological analysis mice were sacrificed at the indicated time, kidneys were collected, weighted and fixed in formalin 10% (BioOptica, #05-01005Q), included in paraffin and cut 5 μm/slides. Kidney sections were air-dried and rehydrated in PBS (Sigma-Aldrich, #P4417). For YAP staining kidney sections were incubated with YAP antibody and 5 min in Eosin G (BioOptica, #05-10002/L); For Ki67 staining kidney sections were incubated with Ki67 antibody and 2 min in Hematoxylin (BioOptica, #05-06015/L). Sections were then washed, processed through a dehydration alcohol scale and mounted in DPX (Sigma-Aldrich, #06522). For the semi-automated quantification, slides were acquired with Aperio AT2 digital scanner at magnification of 40 × (Leica Biosystems) and analyzed with Imagescope (Leica Biosystem). YAP and Ki67 nuclear staining per cyst was performed by Aperio Image analysis software (Leica Biosystems) and counted manually.
+ Open protocol
+ Expand
4

Quantitative IHC and IF Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All organs were fixed in 10% neutral buffered formalin for 48 hours prior to paraffin-embedding and sectioning. All IHC staining was completed on the Leica Biosystems BOND MAX platform (Buffalo Grove, IL), antibodies used for chromogenic IHC staining and tissue immunofluorescence are listed in Supplementary Table S1.
IHC images were acquired using the Aperio AT2 Whole Slide Digital Scanner (Leica Biosystems) at 20× magnification. Quantitative analysis was performed by Aperio Image Analysis Software (Leica Biosystems) employing membrane (E-cadherin, CK19), nuclear (Ki67), and positive pixel count algorithms (collagen, smooth muscle actin).
For phospho-SMAD2/SMA immunofluorescence costaining, 5-μm–thick sections were deparaffinized, followed by 10 minutes of heat-induced epitope retrieval in citrate (phospho-SMAD2/SMA) or EDTA buffer (phospho-STAT3/SMA double staining). Primary antibodies were incubated for 60 minutes and secondary antibodies for 30 minutes with UltraCruz background blocking performed one hour prior. Tissues were manually counterstained with DAPI combined with mounting medium. Fluorescent images were acquired using the Aperio FL Multi-channel Fluorescence Slide Scanner (Leica Biosystems) at 20× magnification, and quantitative analysis was performed by HALO Image Analysis (Indica Labs) utilizing the High-Plex FL v3.0.3 Classifier Algorithm.
+ Open protocol
+ Expand
5

Quantifying Cellular Proliferation in Formalin-Fixed Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four μm-thick sections of formalin-fixed paraffin-embedded (FFPE) explant tissue were stained for the proliferative marker Ki67. Automated immunohistochemistry (IHC) was carried out on a Discovery XT staining module (Roche). Antigen was retrieved by incubating slides in Cell Conditioning Solution (Roche). Endogenous peroxidase activity was reduced by incubating slides in Inhibitor CM (Roche). Slides were incubated in Ki67 primary antibody (Novocastra; 1:100) or Anit-AR primary antibody (clone G122-434, BD) for 1 h at 37°C followed by HRP-conjugated Discovery OmniMaP HRP secondary antibody (Roche) for 30 min. A ChromoMap DAB kit (Roche) was used for detection. Slides were counterstained in hematoxylin and mounted in DPX. Stained slides were imaged using an Aperio CS2 Digital Pathology scanner (Leica). Regions of interest (i.e. epithelial cells) were manually annotated and the percentage of Ki67 positive cells was determined using Aperio Image Analysis software (Leica) in a minimum of four representative 40× magnification regions containing a total of at least 1000 nuclei. Positive control tissue for Ki67 is shown in Supplementary Figure S8 alongside no primary control staining. Serial sections were also stained for p63 (basal cell marker identifying benign regions) and AMACR (cancer cell marker) to define regions of cancer (Supplementary Figure S9).
+ Open protocol
+ Expand
6

Quantitative Analysis of Tumor Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues were formalin-fixed and paraffin-embedded as previously described (21 (link)). Antibody information is provided in STable 1. For staining quantification, slides were scanned into the Aperio Image Analysis software (Leica, Buffalo Grove, IL). The total tumor area was quantified by removing necrotic and stromal areas. Custom algorithms for specific stains were used to quantify stain intensity or percent positive stain as assessed by percent weak, medium, and strong determined using the color-deconvolution tool.
+ Open protocol
+ Expand
7

Nuclei Quantification and IHC Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Individual nuclei counts were counted from H&E sections (normalized to a length of 300 µm) using the Nuclei Seg plugin of the Halo image analysis platform. IHC staining was quantified using Leica Aperio image analysis software. Pixels were classified as negative, weak, medium, and strong positive, counted, and divided by the total number of pixels.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!